本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Olema Pharmaceuticals, Inc.

28.18
+0.25000.90%
盤後28.310.1300+0.46%19:33 EST
成交量:237.56萬
成交額:6,650.22萬
市值:22.17億
市盈率:-15.60
高:28.98
開:27.92
低:26.40
收:27.93
52周最高:36.26
52周最低:2.86
股本:7,865.99萬
流通股本:5,314.44萬
量比:0.69
換手率:4.47%
股息:- -
股息率:- -
每股收益(TTM):-1.8064
每股收益(LYR):-2.2041
淨資產收益率:-59.22%
總資產收益率:-34.41%
市淨率:7.21
市盈率(LYR):-12.79

資料載入中...

2024/05/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/15

重要事件披露

Form 8-K - Current report
2024/05/08

重要事件披露

Form 8-K - Current report
2024/05/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/22

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/03/11

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/11

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/11

重要事件披露

Form 8-K - Current report
2024/03/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/15

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/08

SEC問詢函

Form CORRESP - Correspondence
2024/02/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/08

重要事件披露

Form 8-K - Current report
2024/01/08

重要事件披露

Form 8-K - Current report